{
    "title": "Softbank-backed Neumora's depression drug cuts symptoms in mid-stage trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12310419/Softbank-backed-Neumoras-depression-drug-cuts-symptoms-mid-stage-trial.html",
    "date": "2023-07-18",
    "keywords": [
        "drug",
        "depression",
        "mdd",
        "trial",
        "navacaprant",
        "disorder",
        "company",
        "role",
        "executive",
        "midstage",
        "vision",
        "fund",
        "amgen",
        "measure",
        "feature",
        "capacity",
        "pleasure",
        "treatment",
        "brain",
        "chemical",
        "dopamine",
        "rewardprocessing",
        "cognition",
        "reward",
        "acquisition",
        "significance",
        "placebo",
        "week",
        "goal",
        "study",
        "year",
        "government",
        "developer",
        "henry",
        "ceo",
        "cofounder",
        "paul",
        "chairman",
        "board",
        "neumora",
        "reporting",
        "vaibhav",
        "sadhamta",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "pooja",
        "desai"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}